Sedia Biosciences

company

About

Sedia Biosciences develops and sells medical diagnostic tests and monitoring tools used to battle against pandemics.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.80M
Industries
Biotechnology,Health Diagnostics
Founded date
Jan 1, 2009
Number Of Employee
11 - 50
Operating Status
Active

It is Sedia's mission to provide more cost effective and accessible diagnostic testing by advancing the widespread use of innovative surveillance and monitoring tools, and point-of-care diagnostic testing.

Our objectives are to become a leader in advancing access to medical care by (1) focusing on point-of-care diagnostics and (2) developing innovative diagnostic, surveillance and monitoring tools that enable more cost effective deployment of resources by healthcare providers.

With headquarters in Portland, Oregon, USA, Sedia brings together a dedicated team of researchers and scientists that share our common mission - to improve access to medical care around the world by providing innovative diagnostic products.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$2M
Sedia Biosciences has raised a total of $2M in funding over 2 rounds. Their latest funding was raised on Aug 30, 2016 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 30, 2016 Grant $1.80M 1 Detail
Aug 19, 2014 Grant $200K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Sedia Biosciences is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Grant